Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become widely used for weight management because it reduces hunger signals in the brain and slows gastric emptying. The dose your body needs depends on your individual response, metabolic factors, and weight loss goals—not a one-size-fits-all protocol. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, with transparent pricing that covers any dose adjustment you may need.
Understanding Semaglutide Dosing Protocols
Semaglutide weight loss therapy uses a step-up dosing approach designed to minimize side effects while building tolerance. Most protocols begin at 0.25 mg injected subcutaneously once weekly, with increases of 0.25 mg every four weeks until reaching a maintenance dose between 1.0 mg and 2.4 mg weekly. This gradual escalation allows your gastrointestinal system to adapt and helps you find the lowest effective dose for your body's response.
The reason for this titration strategy is both safety and efficacy: starting low reduces nausea and digestive upset, while steady increases allow your body to signal satiety at progressively lower calorie intake. Clinical trials show that participants who reach 2.4 mg weekly experience the greatest weight loss, but substantial results often occur at 1.0 mg or 1.7 mg for many individuals. Your specific dose target depends on tolerability, weight loss progress, and your healthcare provider's assessment.
Factors That Determine Your Ideal Semaglutide Dose
Multiple biological and lifestyle factors influence which semaglutide dose works best for your weight loss journey. Metabolic rate, baseline body weight, insulin sensitivity, appetite hormones, and genetic variations in GLP-1 receptor function all play roles in how your body responds to the medication. Your diet quality, physical activity level, and sleep patterns also affect whether you reach your goals at 1.0 mg weekly or need titration closer to 2.4 mg.
The PlexusDx Precision Peptide Genetic Test identifies key genetic variants—including GLP1R rs6923761 and GIPR rs1800437—that influence how effectively your body's GLP-1 pathways respond to semaglutide. Understanding these genetic predispositions helps your healthcare provider predict dose responsiveness and anticipate which individuals may achieve results at lower doses or require higher titration. This personalized insight reduces trial-and-error and accelerates progress toward your weight loss targets.
Maintenance Dose vs. Starting Dose for Weight Loss
The distinction between starting dose and maintenance dose is critical for managing expectations and side effects. Your starting dose of 0.25 mg is intentionally low and is not expected to produce major weight loss; instead, it primes your body's GLP-1 receptors and introduces the medication's effects gradually. Meaningful weight loss typically emerges after reaching 1.0 mg or higher, where appetite suppression becomes pronounced enough to support sustained calorie deficit.
Most patients achieve clinically significant weight loss—5-10% of body weight—at maintenance doses between 1.0 mg and 1.7 mg weekly, with some requiring the maximum 2.4 mg dose. The goal is finding the lowest dose that produces your desired weight loss while keeping side effects manageable. Once you reach an effective maintenance dose, it typically remains stable; PlexusDx pricing stays flat at $149/month whether you're at 0.25 mg during titration or 2.4 mg at maintenance, removing financial barriers to dose optimization.
Adjusting Your Dose Based on Response and Tolerance
Your semaglutide dose is not permanent and should be adjusted based on your body's response every four weeks during titration. If you experience intolerable nausea, constipation, or vomiting, your provider may slow the titration schedule or hold your dose steady longer before advancing. Conversely, if you tolerate each dose well and weight loss is progressing, moving to the next 0.25 mg increment is typically the next step.
Some individuals plateau in weight loss at a particular dose and may benefit from advancing further; others reach their personal weight loss goal and can stabilize at that level indefinitely. Your healthcare provider monitors progress through weight measurements, hunger levels, and your reported side effect burden to make informed dose adjustments. Since PlexusDx compounded semaglutide injection is available through licensed 503A pharmacies serving all 50 states with no insurance required, you can adjust your dose without worrying about cost changes—your monthly price remains $149 regardless of dose level.
Common Dosing Questions About Semaglutide for Weight Loss
Patients frequently ask whether a higher dose always produces better results, and the answer is nuanced. While higher doses do increase appetite suppression, they also increase the risk of side effects like nausea and gastrointestinal distress. The optimal dose is the one that produces your desired weight loss outcome with side effects you can tolerate—often lower than the maximum possible dose.
Another common concern is whether you'll need to stay on semaglutide indefinitely. Current evidence suggests that weight regain occurs in many individuals who discontinue GLP-1 therapy, though some maintain weight loss long-term. This reflects that semaglutide addresses appetite regulation rather than curing underlying metabolic conditions; your doctor can discuss whether maintenance therapy, periodic dosing, or other strategies align with your long-term goals. PlexusDx makes ongoing access affordable by eliminating flat per-compound pricing variability, so the cost of your maintenance therapy remains predictable.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide, and why is it so low?
Semaglutide weight loss therapy begins at 0.25 mg injected once weekly because this dose allows your gastrointestinal system to adapt and minimizes side effects like nausea. Your body needs time to become accustomed to GLP-1 receptor stimulation; starting low is safer and improves tolerability as you titrate upward over four-week intervals.
How long does it take to reach the maintenance dose?
Reaching a maintenance dose typically requires 12–20 weeks of titration, depending on your tolerability and weight loss progress. Standard protocols increase the dose by 0.25 mg every four weeks until reaching your target dose between 1.0 mg and 2.4 mg weekly. Your healthcare provider may adjust this timeline if you experience side effects or plateau in weight loss.
Can I stay on a lower dose and still lose weight?
Yes, many patients achieve meaningful weight loss at doses lower than 2.4 mg, including 1.0 mg and 1.7 mg. Your ideal dose depends on your individual metabolic response, genetic factors, and tolerability. The PlexusDx Precision Peptide Genetic Test can help predict your GLP-1 receptor sensitivity and inform your provider's dosing strategy.
What does PlexusDx charge for semaglutide, and does price change with dose increases?
PlexusDx compounded semaglutide injection starts at $149/month flat—your price does not increase when your dose goes up. You pay the same monthly fee whether you're titrating at 0.25 mg or maintaining at 2.4 mg, delivered from licensed 503A compounding pharmacies serving all 50 states, no insurance required.
What genetic factors affect how well semaglutide works for me?
Your GLP1R and GIPR genes influence how sensitive your appetite-regulating pathways are to semaglutide stimulation. The PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761 and GIPR rs1800437, mapping 14 pathways and 49 peptides to predict your likely dose responsiveness and optimize your personalized treatment approach.
What happens if I reach a dose but experience too many side effects?
If side effects become intolerable, your provider can reduce your dose by one step (0.25 mg) or hold your current dose longer before advancing. Some individuals find their optimal balance at a lower dose with fewer side effects but still adequate weight loss; dose adjustment is normal and encouraged based on your personal response.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Quickly Can I Lose Weight on Ozempic?
Who Cannot Take Wegovy for Weight Loss? Understanding the Restrictions and Considerations